The benefits of sequencing adjuvant tamoxifen and anastrozole in postmenopausal women with hormone-responsive early breast cancer: 5 year-analysis of ABCSG Trial 8

被引：0
|
作者：
Jakesz, R [1 ]
Gnant, M [1 ]
Greil, R [1 ]
Tausch, C [1 ]
Samonigg, H [1 ]
Kwasny, W [1 ]
Kubista, E [1 ]
Stierer, M [1 ]
Luschin, G [1 ]
Mittlboeck, M [1 ]
机构：
[1] Vienna Med Sch, Vienna, Austria
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [31] Comparison of adverse effects on lipid metabolism of Anastrozole with Tamoxifen in adjuvant setting for postmenopausal women with early breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 94 - 94
  • [32] Health economic assessment of the ATAC trial comparing anastrozole versus tamoxifen in adjuvant treatment of postmenopausal hormone receptor positive early breast cancer
    Annemans, L
    Moeremans, K
    Lamarque, H
    VALUE IN HEALTH, 2003, 6 (06) : 625 - 625
  • [33] Australian cost-effectiveness analysis of anastrozole vs tamoxifen in postmenopausal women with early breast cancer based on the 5-year completed treatment analysis of the ATAC trial
    Benedict, A
    Theodoratou, D
    Maclean, A
    Norris, S
    Campbell, S
    Mernagh, P
    VALUE IN HEALTH, 2005, 8 (06) : A39 - A39
  • [34] Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy for postmenopausal women with early hormone-receptor positive breast cancer - an evaluation of the ATAC-trial.
    Lundkvist, J.
    Paulsson, T.
    Borgstrom, F.
    Kasteng, F.
    Sobocki, P.
    Lidgren, M.
    Henriksson, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S229 - S229
  • [35] Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole
    Menada, Mario Valenzano
    Costantini, Sergio
    Moioli, Melita
    Bogliolo, Stefano
    Papadia, Andrea
    Ferrero, Simone
    Dugnani, Maria Cristina
    BREAST, 2008, 17 (06): : 631 - 636
  • [36] Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast Cancer
    Mrozek, Ewa
    Layman, Rachel
    Ramaswamy, Bhuvaneswari
    Schaaf, Larry
    Li, Xiaobai
    Ottman, Susan
    Shapiro, Charles L.
    CLINICAL BREAST CANCER, 2012, 12 (02) : 151 - 156
  • [37] Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormonesensitive early-stage breast cancer: a meta-analysis
    Jonat, Walter
    Gnant, Michael
    Boccardo, Francesco
    Kaufmann, Manfred
    Rubagotti, Alessandro
    Zuna, Ivan
    Greenwood, Mike
    Jakesz, Raimund
    LANCET ONCOLOGY, 2006, 7 (12): : 991 - 996
  • [38] Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
    Cuzick, Jack
    Sestak, Ivana
    Baum, Michael
    Buzdar, Aman
    Howell, Anthony
    Dowsett, Mitch
    Forbes, John F.
    LANCET ONCOLOGY, 2010, 11 (12): : 1135 - 1141
  • [39] Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group
    Dubsky, Peter C.
    Jakesz, Raimund
    Mlineritsch, Brigitte
    Poestlberger, Sabine
    Samonigg, Hellmut
    Kwasny, Werner
    Tausch, Christoph
    Stoeger, Herbert
    Haider, Karin
    Fitzal, Florian
    Singer, Christian F.
    Stierer, Michael
    Sevelda, Paul
    Luschin-Ebengreuth, Gero
    Taucher, Susanne
    Rudas, Margaretha
    Bartsch, Rupert
    Steger, Guenther G.
    Greil, Richard
    Filipcic, Lidija
    Gnant, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (07) : 722 - 728
  • [40] Anastrozole is superior to tamoxifen in the treatment of postmenopausal women with early breast cancer - first results of the ATAC ('Arimidex', Tamoxifen, alone or in combination) trial
    Sainsbury, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 137 - 137
12345